Compositions and methods relating to breast specific genes and proteins
    22.
    发明申请
    Compositions and methods relating to breast specific genes and proteins 审中-公开
    与乳腺特异性基因和蛋白质有关的组成和方法

    公开(公告)号:US20060051759A1

    公开(公告)日:2006-03-09

    申请号:US10517696

    申请日:2003-06-16

    IPC分类号: C12Q1/68 C07H21/04

    摘要: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying diagnosing, monitoring, staging, imaging and treating breast cancer and non-cancerous disease states in breast, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.

    摘要翻译: 本发明涉及存在于正常和肿瘤性乳腺细胞中的新鉴定的核酸分子和多肽,包括核酸和多肽的片段,变体和衍生物。 本发明还涉及本发明多肽的抗体,以及本发明多肽的激动剂和拮抗剂。 本发明还涉及含有本发明的核酸分子,多肽,抗体,激动剂和拮抗剂以及使用这些组合物的方法的组合物。 这些用途包括鉴定诊断,监测,分期,成像和治疗乳腺癌和非癌性疾病状态,识别乳腺组织,监测和鉴定和/或设计本发明多肽的激动剂和拮抗剂。 用途还包括基因治疗,转基因动物和细胞的生产,以及用于治疗和研究的工程乳腺组织的生产。

    Compositions and methods relating to endometrial specific genes and proteins
    24.
    发明申请
    Compositions and methods relating to endometrial specific genes and proteins 审中-公开
    与子宫内膜特异性基因和蛋白质有关的组成和方法

    公开(公告)号:US20050123551A1

    公开(公告)日:2005-06-09

    申请号:US10499353

    申请日:2002-12-20

    摘要: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic endometrial cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating endometrial cancer and non-cancerous disease states in endometrial, identifying endometrial tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered endometrial tissue for treatment and research.

    摘要翻译: 本发明涉及存在于正常和肿瘤性子宫内膜细胞中的新鉴定的核酸分子和多肽,包括核酸和多肽的片段,变体和衍生物。 本发明还涉及本发明多肽的抗体,以及本发明多肽的激动剂和拮抗剂。 本发明还涉及含有本发明的核酸分子,多肽,抗体,激动剂和拮抗剂以及使用这些组合物的方法的组合物。 这些用途包括识别,诊断,监测,分期,成像和治疗子宫内膜中的子宫内膜癌和非癌性疾病状态,鉴定子宫内膜组织,监测和鉴定和/或设计本发明多肽的激动剂和拮抗剂。 用途还包括基因治疗,转基因动物和细胞的产生,以及用于治疗和研究的工程子宫内膜组织的产生。

    Compositions and methods relating to ovarian specific genes and proteins
    28.
    发明授权
    Compositions and methods relating to ovarian specific genes and proteins 失效
    与卵巢特异性基因和蛋白质有关的组成和方法

    公开(公告)号:US07678889B2

    公开(公告)日:2010-03-16

    申请号:US10523834

    申请日:2003-08-06

    IPC分类号: C07K16/00

    摘要: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic ovarian cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and noncancerous disease states in ovarian, identifying ovarian tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovarian tissue for treatment and research.

    摘要翻译: 本发明涉及存在于正常和肿瘤性卵巢细胞中的新鉴定的核酸分子和多肽,包括核酸和多肽的片段,变体和衍生物。 本发明还涉及本发明多肽的抗体,以及本发明多肽的激动剂和拮抗剂。 本发明还涉及含有本发明的核酸分子,多肽,抗体,激动剂和拮抗剂以及使用这些组合物的方法的组合物。 这些用途包括在卵巢中识别,诊断,监测,分期,成像和治疗卵巢癌和非癌性疾病状态,鉴定卵巢组织,监测和鉴定和/或设计本发明多肽的激动剂和拮抗剂。 用途还包括基因治疗,转基因动物和细胞的生产,以及用于治疗和研究的工程化卵巢组织的生产。

    Compositions and methods relating to colon specific genes and proteins
    29.
    发明授权
    Compositions and methods relating to colon specific genes and proteins 失效
    与结肠特异性基因和蛋白质有关的组成和方法

    公开(公告)号:US07361475B2

    公开(公告)日:2008-04-22

    申请号:US11042241

    申请日:2005-01-25

    摘要: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic colon cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating colon cancer and non-cancerous disease states in colon tissue, identifying colon tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered colon tissue for treatment and research.

    摘要翻译: 本发明涉及存在于正常和肿瘤性结肠细胞中的新鉴定的核酸和多肽,包括核酸和多肽的片段,变体和衍生物。 本发明还涉及本发明多肽的抗体,以及本发明多肽的激动剂和拮抗剂。 本发明还涉及包含本发明的核酸,多肽,抗体,变体,衍生物,激动剂和拮抗剂以及使用这些组合物的方法的组合物。 这些用途包括鉴定,诊断,监测,分期,成像和治疗结肠组织中的结肠癌和非癌性疾病状态,鉴定结肠组织,监测和鉴定和/或设计本发明多肽的激动剂和拮抗剂。 用途还包括基因治疗,转基因动物和细胞的生产以及用于治疗和研究的工程结肠组织的生产。